Literature DB >> 9437315

Clinical features of autosomal dominant congenital nystagmus linked to chromosome 6p12.

J B Kerrison1, R K Koenekoop, V J Arnould, D Zee, I H Maumenee.   

Abstract

PURPOSE: To describe the clinical features of a large pedigree with autosomal dominant congenital nystagmus linked to chromosome 6p12.
METHODS: In a prospective evaluation of 54 living family members in a single pedigree, 21 persons were affected with autosomal dominant congenital nystagmus, and clinical examinations were performed on 14. Selected persons underwent further studies, including electroretinography, scanning laser ophthalmoscopy, nerve fiber layer studies, visual evoked potential studies, and eye movement recordings.
RESULTS: Among seven affected persons whose parents were able to report whether the nystagmus was present congenitally, onset at birth was noted in two persons and between 3 and 6 months in five persons. Best-corrected binocular Snellen visual acuity ranged from 20/30 to 20/100, with a mode of 20/50. Strabismus was present in 14 examined patients (36%). Eye movement recordings, performed on five persons, included asymmetric pendular (three), asymmetric pendular combined with dual waveform jerk (one), and unidirectional jerk nystagmus (one).
CONCLUSIONS: Autosomal dominant congenital nystagmus represents a disorder with variable expressivity. While onset is typically during infancy, it can be noted at birth. Intrafamilial variation in visual acuity, ocular alignment, and nystagmus waveform suggests a role for modifying influences on expression of disease.

Entities:  

Mesh:

Year:  1998        PMID: 9437315     DOI: 10.1016/s0002-9394(99)80236-0

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  8 in total

1.  Congenital motor nystagmus linked to Xq26-q27.

Authors:  J B Kerrison; M R Vagefi; M M Barmada; I H Maumenee
Journal:  Am J Hum Genet       Date:  1999-02       Impact factor: 11.025

2.  CASK mutations are frequent in males and cause X-linked nystagmus and variable XLMR phenotypes.

Authors:  Anna Hackett; Patrick S Tarpey; Andrea Licata; James Cox; Annabel Whibley; Jackie Boyle; Carolyn Rogers; John Grigg; Michael Partington; Roger E Stevenson; John Tolmie; John Rw Yates; Gillian Turner; Meredith Wilson; Andrew P Futreal; Mark Corbett; Marie Shaw; Jozef Gecz; F Lucy Raymond; Michael R Stratton; Charles E Schwartz; Fatima E Abidi
Journal:  Eur J Hum Genet       Date:  2009-12-23       Impact factor: 4.246

3.  Clinical and Oculographic Findings of X-linked Congenital Nystagmus in Three Korean Families.

Authors:  Sun-Young Oh; Byong-Soo Shin; Ki-Young Jeong; Jeong-Min Hwang; Ji Soo Kim
Journal:  J Clin Neurol       Date:  2007-09-20       Impact factor: 3.077

4.  Novel mutation c.980_983delATTA compound with c.986C>A mutation of the FRMD7 gene in a Chinese family with X-linked idiopathic congenital nystagmus.

Authors:  Feng-wei Song; Bin-bin Chen; Zhao-hui Sun; Li-ping Wu; Su-juan Zhao; Qi Miao; Xia-jing Tang
Journal:  J Zhejiang Univ Sci B       Date:  2013-06       Impact factor: 3.066

5.  Identification of a novel GPR143 mutation in a large Chinese family with congenital nystagmus as the most prominent and consistent manifestation.

Authors:  Jing Yu Liu; Xiang Ren; Xiufeng Yang; Tangying Guo; Qi Yao; Lin Li; Xiaohua Dai; Mingchang Zhang; Lejin Wang; Mugen Liu; Qing K Wang
Journal:  J Hum Genet       Date:  2007-05-22       Impact factor: 3.172

6.  The Role of FRMD7 in Idiopathic Infantile Nystagmus.

Authors:  Rachel J Watkins; Mervyn G Thomas; Chris J Talbot; Irene Gottlob; Sue Shackleton
Journal:  J Ophthalmol       Date:  2011-08-29       Impact factor: 1.909

7.  Oculomotor neurocircuitry, a structural connectivity study of infantile nystagmus syndrome.

Authors:  Nasser H Kashou; Angelica R Zampini
Journal:  PLoS One       Date:  2015-04-10       Impact factor: 3.240

8.  Identification of a novel GPR143 deletion in a Chinese family with X-linked congenital nystagmus.

Authors:  Pingtong Zhou; Zhiqiang Wang; Jing Zhang; Landian Hu; Xiangyin Kong
Journal:  Mol Vis       Date:  2008-05-30       Impact factor: 2.367

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.